---
title: Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment
  and Reduce Lung Cancer Regrowth after Crizotinib Treatment
date: '2024-04-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38626916/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240417180658&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: ALK-positive NSCLC patients demonstrate initial responses to ALK tyrosine
  kinase inhibitor (TKI) treatments, but eventually develop resistance, causing rapid
  tumor relapse and poor survival rates. Growing evidence suggests that the combination
  of drug and immune therapies greatly improves patient survival; however, due to
  the low immunogenicity of the tumors, ALK-positive patients do not respond to currently
  available immunotherapies. Tumor-associated macrophages (TAMs) play a crucial role
  ...
disable_comments: true
---
ALK-positive NSCLC patients demonstrate initial responses to ALK tyrosine kinase inhibitor (TKI) treatments, but eventually develop resistance, causing rapid tumor relapse and poor survival rates. Growing evidence suggests that the combination of drug and immune therapies greatly improves patient survival; however, due to the low immunogenicity of the tumors, ALK-positive patients do not respond to currently available immunotherapies. Tumor-associated macrophages (TAMs) play a crucial role ...